Neil Gagnon - May 21, 2021 Form 4 Insider Report for Apollo Endosurgery, Inc. (APEN)

Role
10%+ Owner
Signature
/s/ Neil Gagnon
Stock symbol
APEN
Transactions as of
May 21, 2021
Transactions value $
$129
Form type
4
Date filed
6/15/2021, 04:57 PM
Next filing
Jul 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APEN Common Stock, $0.001 par value per share Other $0 +8.05K +2% $0.00 411K May 21, 2021 Direct F3
transaction APEN Common Stock, $0.001 par value per share Other $0 +1.61K +1.95% $0.00 84K May 21, 2021 By Limited Partner of the Family Partnership F3
transaction APEN Common Stock, $0.001 par value per share Exercise of in-the-money or at-the-money derivative security $129 +129K +10.71% $0.00* 1.33M Jun 11, 2021 By Managing Member as General Partner of Gagnon Investment Associates F1
holding APEN Common Stock, $0.001 par value per share 116K May 21, 2021 By Managing Member as General Partner of Darwin Partnership F1
holding APEN Common Stock, $0.001 par value per share 26.4K May 21, 2021 By self as Trustee of Gagnon Securities LLC Profit Sharing Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APEN Pre-funded warrants Exercise of in-the-money or at-the-money derivative security $0 -129K -100% $0.00* 0 Jun 11, 2021 Common Stock, $0.001 par value per share 129K $0.00 As Managing Member of General Partner of Gagnon Investment Associates F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Neil Gagnon serves as the Chief Executive Officer of Gagnon Advisors, LLC and is the managing member and principal owner of Gagnon Securities LLC, each of which provide investment management services to investment vehicles and managed accounts (collectively, the "Accounts"), and as such, has investment discretion with respect to the Accounts. Mr. Gagnon's interest in the securities reported herein is limited to the extent of his pecuniary interest in each of the Accounts, if any.
F2 These warrants were currently exercisable and did not have an expiration date.
F3 The shares of common stock were received as an in-kind quarterly interest payment with respect to the 6.0% Convertible Debentures due 2024 (the "Debentures") held by the Darwin Partnership. The Debentures will mature on August 12, 2024 unless earlier converted or repurchased in accordance with their terms. The Debentures are convertible, at the option of the holders, into shares of common stock at an initial conversion price of $3.25 per share, subject to adjustment. If the VWAP of the Issuer's common stock has been at least $9.75 (subject to adjustment) for at least 20 trading days during any 30 consecutive trading day period, the Issuer may force the conversion of all or any part of the outstanding principal amount of the Debentures, accrued and unpaid interest and any other amounts then owing, subject to certain conditions.